Published

Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Neuroscience applied
Date: 2024-01-01
Source: PubMed
DOI: 10.1016/j.nsa.2024.103938
PubMed: 40656112

Authors

E-Wen McCulloch D Liechti ME Kuypers KP Nutt D Lundberg J Stenbæk DS Goodwin GM Gründer G Butlen-Ducuing F Haberkamp M Thirstrup S Knudsen GM

Watch author

Derived topics and classifications

psilocybin Depression Pharmacology Clinical Trial Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 3 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocols2026-04-01 Psilocybin shapes the slow, global propagation of brain activity over the cortical layout of 5HT2a receptors2026-03-26 Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.2024-01-01

Related papers

No close related records were found yet.